PortfoliosLab logoPortfoliosLab logo
OZEM vs. IHE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

OZEM vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roundhill Glp-1 & Weight Loss ETF (OZEM) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

OZEM vs. IHE - Yearly Performance Comparison


2026 (YTD)20252024
OZEM
Roundhill Glp-1 & Weight Loss ETF
-6.61%41.87%-3.78%
IHE
iShares U.S. Pharmaceuticals ETF
3.70%31.69%0.28%

Returns By Period

In the year-to-date period, OZEM achieves a -6.61% return, which is significantly lower than IHE's 3.70% return.


OZEM

1D
2.24%
1M
-4.47%
YTD
-6.61%
6M
13.53%
1Y
39.36%
3Y*
5Y*
10Y*

IHE

1D
1.15%
1M
-3.66%
YTD
3.70%
6M
18.16%
1Y
32.13%
3Y*
16.43%
5Y*
10.17%
10Y*
8.20%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


OZEM vs. IHE - Expense Ratio Comparison

OZEM has a 0.59% expense ratio, which is higher than IHE's 0.42% expense ratio.


Return for Risk

OZEM vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OZEM
OZEM Risk / Return Rank: 6767
Overall Rank
OZEM Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
OZEM Sortino Ratio Rank: 7676
Sortino Ratio Rank
OZEM Omega Ratio Rank: 6565
Omega Ratio Rank
OZEM Calmar Ratio Rank: 6969
Calmar Ratio Rank
OZEM Martin Ratio Rank: 5151
Martin Ratio Rank

IHE
IHE Risk / Return Rank: 7878
Overall Rank
IHE Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 8181
Sortino Ratio Rank
IHE Omega Ratio Rank: 7575
Omega Ratio Rank
IHE Calmar Ratio Rank: 8383
Calmar Ratio Rank
IHE Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OZEM vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roundhill Glp-1 & Weight Loss ETF (OZEM) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OZEMIHEDifference

Sharpe ratio

Return per unit of total volatility

1.43

1.59

-0.16

Sortino ratio

Return per unit of downside risk

2.01

2.20

-0.19

Omega ratio

Gain probability vs. loss probability

1.25

1.29

-0.04

Calmar ratio

Return relative to maximum drawdown

1.91

2.52

-0.61

Martin ratio

Return relative to average drawdown

5.21

7.93

-2.71

OZEM vs. IHE - Sharpe Ratio Comparison

The current OZEM Sharpe Ratio is 1.43, which is comparable to the IHE Sharpe Ratio of 1.59. The chart below compares the historical Sharpe Ratios of OZEM and IHE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


OZEMIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.43

1.59

-0.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.64

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

Sharpe Ratio (All Time)

Calculated using the full available price history

0.55

0.50

+0.05

Correlation

The correlation between OZEM and IHE is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

OZEM vs. IHE - Dividend Comparison

OZEM's dividend yield for the trailing twelve months is around 1.28%, less than IHE's 1.70% yield.


TTM20252024202320222021202020192018201720162015
OZEM
Roundhill Glp-1 & Weight Loss ETF
1.28%1.20%0.22%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IHE
iShares U.S. Pharmaceuticals ETF
1.70%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Drawdowns

OZEM vs. IHE - Drawdown Comparison

The maximum OZEM drawdown since its inception was -28.65%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for OZEM and IHE.


Loading graphics...

Drawdown Indicators


OZEMIHEDifference

Max Drawdown

Largest peak-to-trough decline

-28.65%

-38.20%

+9.55%

Max Drawdown (1Y)

Largest decline over 1 year

-19.11%

-10.58%

-8.53%

Max Drawdown (5Y)

Largest decline over 5 years

-16.03%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

Current Drawdown

Current decline from peak

-13.81%

-4.22%

-9.59%

Average Drawdown

Average peak-to-trough decline

-8.31%

-7.95%

-0.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.98%

3.36%

+3.62%

Volatility

OZEM vs. IHE - Volatility Comparison

Roundhill Glp-1 & Weight Loss ETF (OZEM) has a higher volatility of 6.54% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 5.91%. This indicates that OZEM's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


OZEMIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.54%

5.91%

+0.63%

Volatility (6M)

Calculated over the trailing 6-month period

17.55%

12.12%

+5.43%

Volatility (1Y)

Calculated over the trailing 1-year period

27.70%

20.70%

+7.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.39%

15.95%

+9.44%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.39%

18.11%

+7.28%